TABLE 1.
Thirty-day follow-up for each of the three patients.
| Patient 1 | Patient 2 | Patient 3 | |
| Pacemaker implantation | No | No | No |
| Renal impairment | No | No | No |
| Body surface area, m2* | 2.18 | 2.31 | 2.39 |
| Body mass index, kg/m2 | 35.1 | 32.8 | 30.4 |
| TTE-follow up | |||
| Trans prosthetic Mean PG, mmHg | 7 | 4 | 7 |
| EOA, cm2 | 2.0 | † | 2.7 |
| EOA index | 0.92‡ | 1.1 | |
| PVL | Trace | Trace | Trace |
| LV-EF% | 50 | 50 | 55 |
*The three patients have relatively large BSA and high BMI. †EOA was not measured due to the missing mandatory parameters for the continuity equation. ‡EOA index is acceptable regarding the patients’ high BMI. TTE, Trans thoracic echocardiogram; PG, Pressure gradient; EOA, Effective orifice area; PVL, paravalvular leakage; LV-EF, Left ventricle-ejection fraction.